Trexquant Investment LP - RUBIUS THERAPEUTICS INC ownership

RUBIUS THERAPEUTICS INC's ticker is RUBY and the CUSIP is 78116T103. A total of 78 filers reported holding RUBIUS THERAPEUTICS INC in Q1 2020. The put-call ratio across all filers is - and the average weighting 0.4%.

Quarter-by-quarter ownership
Trexquant Investment LP ownership history of RUBIUS THERAPEUTICS INC
ValueSharesWeighting
Q4 2021$169,000
-64.1%
17,455
-33.7%
0.01%
-73.0%
Q3 2021$471,000
+40.2%
26,321
+91.4%
0.04%
+32.1%
Q2 2021$336,000
+232.7%
13,749
+3.2%
0.03%
+154.5%
Q4 2020$101,000
-44.5%
13,323
-63.4%
0.01%
-8.3%
Q3 2020$182,000
+2.8%
36,363
+22.7%
0.01%0.0%
Q2 2020$177,000
-33.0%
29,642
+6.9%
0.01%
-25.0%
Q4 2019$264,00027,7390.02%
Other shareholders
RUBIUS THERAPEUTICS INC shareholders Q1 2020
NameSharesValueWeighting ↓
Flagship Pioneering Inc. 38,506,526$6,546,1090.21%
HARBOURVEST PARTNERS LLC 986,878$172,7040.06%
Artal Group S.A. 2,042,666$3570.02%
Virtu Financial LLC 68,825$120.00%
ACADIAN ASSET MANAGEMENT LLC 1,277,196$2220.00%
STATE OF MICHIGAN RETIREMENT SYSTEM 640,000$110,1440.00%
Baillie Gifford 4,869,126$837,9770.00%
Citadel Advisors 600$1030.00%
Tower Research Capital LLC (TRC) 25$00.00%
JPMORGAN CHASE & CO 2,196$00.00%
View complete list of RUBIUS THERAPEUTICS INC shareholders